RU-486: As Approval Nears, Abortion Pill May Face New Hurdles
After years of delay, it looks like the FDA is ready to approve the controversial abortion drug, RU-486, for widespread use in the United States. But, as California Healthline's Jeff Stryker finds out, reports of the negotiations with the manufacturer suggest that approval may come with unprecedented restrictions. Will they undermine the drug's promise at a time when access to abortion providers has been shrinking?
More on this ColumnCalifornia Healthline Features is a regular Monday column in California Healthline. Columnists Jeff Stryker and Stephen Robitaille take readers behind the headlines, with in-depth articles, guest editorials and interviews with California newsmakers. Click here for more on the column.
The views represented in this column are those of the columnist or guest editorialist and not of California Healthline or the National Journal Group.